Location of the report | Patient demographics | Time from admission to positive culture | Sensitivity | Directed Treatment | Tenckhoff removed | Comment |
---|---|---|---|---|---|---|
Houston, USA [1] | 15 y/o male | 4 days | S – Amikacin, trimethoprim/sulfamethoxazole, cefoxitin | IV Amikacin and IV cefoxitin. (c) | Yes | Abscess drainage required |
R- doxycycline | ||||||
Portland, USA [2] | 57 y/o male | 7 days | Not reported | PO Erythromycin, IV cephapirin, IV tobramycin.(6 days) | Yes | Catheter leak. No abdominal pain. Patient died at 6 days. |
Copenhagen, Denmark [3] | 35 y/o male | 11 days | S – Amikacin, tobramycin, erythromycin, trimethoprim-sulfamethoxazole | IV Amikacin, IV methicillin (c) | Yes | In renal transplant perioperative period. |
Cleveland, USA [4] | 32 y/o male | 6 days | S – Amikacin, tetracycline | Amikacin, tetracycline (1 month); ciprofloxacin (c, d) | Yes | Reduced aural acuity after amikacin. |
R – gentamicin, tobramycin, erythromycin, trimethoprim/sulfamethoxazole | ||||||
Hong Kong, China [5] | 65 y/o male | - | Not reported | PO Levofloxacin, PO clarithromycin (12 months) | No |  |
Seoul, Korea [6] | 54 y/o female | 7 days | R – isoniazid, rifampicin, ethambutol, streptomycin | IV Ceftizotime, IV amikacin (c) | Yes |  |
Louisiana, USAb[7] | 71 y/o male | 7 days | Not reported | IP Amikacin and cefoxitin (3 weeks); PO doxycycline and rifampicin (3 months) | Yes |  |
83 y/o female | 4 days | Not reported | Ciprofloxacin and clofazimine (c, d) | ? | ||
Madrid, Spain [8] | 42 y/o male | 11 days | Not reported | IV Amikacin and PO doxycycline (20 days) | Yes |  |
40 y/o male | 8 days | Not reported | IV Amikacin and PO doxycycline (1 month) | Yes | ||
Washington, USA [9] | 33 y/o male | 7 days | S – amikacin, kanamycin, clarithromycin, cefmetazole, imipenem, ciprofloxacin, ofloxacin, azithromycin | PO Clarithromycin and PO trimethoprim/sulfamethoxazole (6 months) | Yes |  |
71 y/o female | 4 days | R – tobramycin, erythromycin, doxycycline, minocycline, cefoxitin | IV Amikacin, PO clarithromycin, PO trimethoprim/sulfamethoxazole (3 months) | Yes | ||
S – clarithromycin, cefmetazole, imipenem, sulfisoxazole, ciprofloxacin, ofloxacin | ||||||
I – amikacin, cefoxitin | ||||||
Saudi Arabia [10] | 45 y/o female | 7 days |  | PO Isoniazid, rifampicin, ethambutol. (6 months) | Yes |  |
Nashville, USA [11] | 16 y/o male | 12 days |  | PO Ciprofloxacin, PO trimethoprim/sulfamethoxazole (c) | Yes | Perihepatic collection |
Kfar-Saba, Israel [12] | 65 y/o male | 4 days |  | Minocycline (1 monthd) | Yes | Also bacteraemia |
Tokyo, Japan [13] | 50 y/o male | 3 weeks | Not reported | Amikacin, sulbactam (c,d) | Yes |  |
Singapore, Singapore b[14] | 78 y/o female | 8 days | S – tobramycin, linezolid, clarithromycin, amikacin | IP amikacin, PO ciprofloxacin (3 months) | No | Patient died at 2 months from malignancy |